Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



New Investigator Awards

2019 (Cycle 30)
Novel Immunotherapeutics for Cigarette-Smoking Associated Acute Myeloid Leukemia 2019 (Cycle 30) $990,000
University of Southern California Cancer

2019 (Cycle 29)
Elucidating the genetic basis of nicotine dependence by using electronic health records 2019 (Cycle 29) $743,841
University of California, San Diego Neuroscience of Nicotine Addiction and Treatment

Impact of Chronic Cannabis Exposure on Metabolic Health and Disease 2019 (Cycle 29) $743,386
University of California, Riverside Cardiovascular and Cerebrovascular Disease

Impact of splicing factor mutations in the context of tobacco exposure in lung cancer 2019 (Cycle 29) $736,710
University of California, Santa Cruz Cancer

Community College Smoke free Policies: Disparities, Contexts and Strategies 2019 (Cycle 29) $948,641
Public Health Institute State and Local Tobacco Control Policy Research

Cigarette smoke effects on nitric oxide-dependent muscle regeneration 2019 (Cycle 29) $720,338
University of California, San Diego Environmental Exposure/Toxicology

2019 (Cycle 28)
Tobacco Posts Social Media of Vulnerable, At-Risk Groups 2019 (Cycle 28) $748,149
University of California, San Diego Tobacco-Use Prevention and Cessation

Impact of vape pen placement in music videos on young adults 2019 (Cycle 28) $961,915
University of Southern California State and Local Tobacco Control Policy Research

Multiethnic Risk for Lung Disease: Genetics and Smoking 2019 (Cycle 28) $990,000
University of Southern California Pulmonary Disease

2018 (Cycle 27)
Modulation of hedgehog signaling in tobacco-related emphysema 2018 (Cycle 27) $734,678
University of California, San Francisco Pulmonary Disease

Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma 2018 (Cycle 27) $750,000
University of California, Davis Cancer

Multilevel Study of Lung Cancer Screening Guidelines Implementation 2018 (Cycle 27) $886,353
Palo Alto Medical Foundation Research Institute Cancer

Oncogenic reprogramming of protein translation by DDX3 inact 2018 (Cycle 27) $748,146
University of California, San Francisco Cancer

2011 (Cycle 20)
Role of mGluR7 in nicotine dependence 2011 (Cycle 20) $270,000
University of California, San Diego Nicotine Dependence

Dietary effects on tobacco-related lung cancer 2011 (Cycle 20) $270,000
University of California, Berkeley Cancer

Indoor chemistry of secondhand and thirdhand smoke 2011 (Cycle 20) $271,559
Lawrence Berkeley National Laboratory General Biomedical Science

New Diagnosis of Bladder Cancer: Smokers Opportunity to Quit 2011 (Cycle 20) $269,936
University of California, Los Angeles Cancer

Role of PHLPP1 in Astrocytes and Stroke 2011 (Cycle 20) $300,000
University of California, San Diego Cardiovascular Disease

Snail-Dependent Malignant Conversion of Airway Epithelium 2011 (Cycle 20) $266,934
University of California, Los Angeles Cancer

2010 (Cycle 19)
Neurobiology of Cigarette Craving in Adolescent Smokers 2010 (Cycle 19) $266,435
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Prenatal Toxicity of Traditional and Harm Reducation Tobacco 2010 (Cycle 19) $314,772
University of California, Riverside General Biomedical Science

Nicotinic receptor-lynx interactions 2010 (Cycle 19) $278,797
California Institute of Technology Nicotine Dependence

Pulmonary Rehabilitation in Sleep Disorders affecting COPD 2010 (Cycle 19) $270,000
University of California, San Diego Pulmonary Disease

High resolution imaging & ablation for smoke induced cancer 2010 (Cycle 19) $264,219
University of California, Irvine Cancer

Characterization of Platelet Thromboxane A2 Receptors 2010 (Cycle 19) $277,422
Western University of Health Sciences Cardiovascular Disease

Multiple Salivary Biomarkers for Lung Cancer Detection 2010 (Cycle 19) $241,103
University of California, Los Angeles Cancer

Effects of Resistance Training on Tobacco-Related CVD Risk 2010 (Cycle 19) $270,000
University of California, Los Angeles Cardiovascular Disease

2009 (Cycle 18)
Pharmacological Interventions for Heavy Drinking Smokers 2009 (Cycle 18) $283,371
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Impact of tobacco-smoke on apolipoprotein exchangeability 2009 (Cycle 18) $324,000
Children's Hospital Oakland Research Institute Cardiovascular Disease

NGAL-dependent Apoptosis Resistance in NSCLC 2009 (Cycle 18) $180,000
University of California, Los Angeles Cancer

Novel treatments for COPD with Statins 2009 (Cycle 18) $269,523
University of California, Davis Pulmonary Disease

Impulsivity as a risk factor for nicotine dependence 2009 (Cycle 18) $270,000
University of California, San Diego Nicotine Dependence

Mechanistic studies of secondhand-smoke carcinogenicity 2009 (Cycle 18) $12,610
University of Southern California Cancer

Mechanistic studies of secondhand-smoke carcinogenicity 2009 (Cycle 18) $278,795
Beckman Research Institute of the City of Hope Cancer

Prenatal Nicotine Exposure and Vascular Programming 2009 (Cycle 18) $289,840
Loma Linda University Nicotine Dependence

2008 (Cycle 17)
Community and Family Context of Teen Smoking 2008 (Cycle 17) $270,000
University of California, Los Angeles Public Health, Public Policy, and Economics

Interaction of LDL receptor family members with ligands 2008 (Cycle 17) $266,162
Children's Hospital Oakland Research Institute Cardiovascular Disease

Genetics and Impulsivity in Smoking Initiation 2008 (Cycle 17) $282,860
Veterans Medical Research Foundation Nicotine Dependence

Transcription Regulation of Inflammation by Glucocorticoids 2008 (Cycle 17) $270,000
University of California, Berkeley Pulmonary Disease

2007 (Cycle 16)
Secondhand Smoke and Nontuberculous Mycobacterial Infection 2007 (Cycle 16) $270,000
University of California, San Diego Epidemiology

Targeting the epithelial-mesenchymal transition in HNSCC 2007 (Cycle 16) $270,000
University of California, Los Angeles Cancer

50000 Fold Signal Enhancement for Imaging Vulnerable Plaque 2007 (Cycle 16) $213,845
Huntington Medical Research Institute Cardiovascular Disease

Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation 2007 (Cycle 16) $260,203
University of California, Davis Pulmonary Disease

Engineering Salmonella for lung cancer therapy 2007 (Cycle 16) $187,550
Sidney Kimmel Cancer Center Cancer

Engineering Salmonella for lung cancer therapy 2007 (Cycle 16) $104,050
The Burnham Institute for Medical Research Cancer

2006 (Cycle 15)
Nicotinic Regulation of GABAergic Signaling 2006 (Cycle 15) $70,120
University of California, San Diego Nicotine Dependence

Stem cell regeneration of the airway: effects of smoke 2006 (Cycle 15) $269,443
University of California, Davis Pulmonary Disease

Tobacco Industry Political Strategies After the 1998 MSA 2006 (Cycle 15) $269,000
University of California, San Francisco Public Health, Public Policy, and Economics

Tobacco GeneƻEnvironment Interactions & Minority Asthmatics 2006 (Cycle 15) $299,500
University of California, San Francisco Pulmonary Disease

African Americans: NRT or Alternative Medicine for Cessation 2006 (Cycle 15) $285,000
University of California, San Francisco Tobacco-Use Prevention and Cessation

Modeling ETS Exposure and Dose Using PDA E-Diaries 2006 (Cycle 15) $245,214
San Diego State University Research Foundation Epidemiology

2005 (Cycle 14)
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle 14) $155,791
San Diego State University Research Foundation Cardiovascular Disease

Do receptors mediate the effects of nicotine on anxiety? 2005 (Cycle 14) $291,060
Salk Institute for Biological Studies Nicotine Dependence

Tobacco, acculturation and gastric cancer among Hispanics 2005 (Cycle 14) $179,367
University of California, Davis Epidemiology

Water pipe use, SHS exposure & home policy in Arab Americans 2005 (Cycle 14) $323,068
San Diego State University Research Foundation Epidemiology

Skeletal muscle structure and function in mice lacking VEGF 2005 (Cycle 14) $284,491
University of California, San Diego Pulmonary Disease

Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle 14) $134,074
Scripps Research Institute Cardiovascular Disease

2004 (Cycle 13)
Genomics & transcriptome of oral precncr prgrssion in smkers 2004 (Cycle 13) $189,541
University of California, Los Angeles Epidemiology

Tobacco industry use of diet and obesity issues 2004 (Cycle 13) $267,526
University of California, San Francisco Public Health, Public Policy, and Economics

Smoking and genes as determinants of SLE and RA serverity 2004 (Cycle 13) $52,662
University of California, San Francisco Epidemiology

Curriculum for treating nicotine dependence in psychiatry 2004 (Cycle 13) $269,500
University of California, San Francisco Tobacco-Use Prevention and Cessation

Pulmonary function and genetic variation in smoke metabolism 2004 (Cycle 13) $23,693
University of California, San Francisco Epidemiology

Regulation of a novel airway glandular mucin by smoke 2004 (Cycle 13) $126,126
University of California, Davis Pulmonary Disease

2003 (Cycle 12)
Ethnic and gender variation in nicotine detoxification 2003 (Cycle 12) $424,142
SRI International Epidemiology

The effect of nicotine on brain activity & neurocognition in schizophrenia 2003 (Cycle 12) $167,964
University of California, Irvine Nicotine Dependence

Targeting Hypoxia-inducible Factor to Treat Lung Cancer 2003 (Cycle 12) $509,490
The Burnham Institute for Medical Research Cancer

Smoking-related changes in LDL and atherosclerosis 2003 (Cycle 12) $269,500
University of California, San Diego Cardiovascular Disease

Neuropharmacology of nicotine relapse 2003 (Cycle 12) $149,175
Cedars-Sinai Medical Center Nicotine Dependence

The role of hCDC4 regulation of cyclin E in lung cancer 2003 (Cycle 12) $517,032
Sidney Kimmel Cancer Center Cancer

Reactivity of surface nicotine towards indoor ozone 2003 (Cycle 12) $448,132
Lawrence Berkeley National Laboratory General Biomedical Science

Influences that promote ethnic disparities in smoking 2003 (Cycle 12) $269,971
University of California, San Diego Public Health, Public Policy, and Economics

Peripheral mechanisms of oral cancer pain in a mouse model 2003 (Cycle 12) $265,332
University of California, San Francisco Cancer

2002 (Cycle 11)
MCP-1 and TGFb in pulmonary emphysema 2002 (Cycle 11) $78,241
University of California, San Francisco Pulmonary Disease

Enzymatic targets for anticancer therapy 2002 (Cycle 11) $267,304
J. David Gladstone Institutes Cancer

Modeling sleep disturbance during nicotine withdrawal 2002 (Cycle 11) $424,344
SRI International Nicotine Dependence

Involvement of PI3K pathway in bladder cancer invasion 2002 (Cycle 11) $224,984
University of California, Davis Cancer

2001 (Cycle 10)
The role of P450s in tobacco-mediated lung cancer 2001 (Cycle 10) $295,815
California Toxicology Research Institute Cancer

Assessing nicotine relapse in a mouse model 2001 (Cycle 10) $183,804
SRI International Nicotine Dependence

Nicotinic receptors & synaptic aging 2001 (Cycle 10) $224,973
University of California, San Diego Nicotine Dependence

Remnant lipoproteins, apolipoprotein E4 and atherosclerosis 2001 (Cycle 10) $400,500
J. David Gladstone Institutes Cardiovascular Disease

Deposition of inhaled carcinogens in ETS 2001 (Cycle 10) $210,446
University of California, Irvine General Biomedical Science

Effects of tobacco smoke on airway bactericidal activity 2001 (Cycle 10) $87,079
University of California, Davis Pulmonary Disease

Effect of nicotine on bone marrow cells 2001 (Cycle 10) $520,381
La Jolla Institute for Molecular Medicine Cardiovascular Disease

Pathways of catabolism of oxidized phospholipids 2001 (Cycle 10) $225,000
University of California, San Diego Cardiovascular Disease

The role of P450s in tobacco-mediated lung cancer 2001 (Cycle 10) $147,858
La Jolla Institute for Molecular Medicine Cancer

COPD: oxygen transport and metabolism in skeletal muscle 2001 (Cycle 10) $224,500
University of California, San Diego Pulmonary Disease

Lung cancer therapy with in vivo-generated dendritic cells 2001 (Cycle 10) $225,000
University of California, Los Angeles Cancer

2000 (Cycle 9)
Prospective relationship between risk perception & teen toba 2000 (Cycle 9) $224,884
University of California, San Francisco Epidemiology

Understanding and preventing college smoking 2000 (Cycle 9) $122,377
University of Southern California Epidemiology

To identify Egr-1 target genes important in pulmonary disease 2000 (Cycle 9) $430,539
The Burnham Institute for Medical Research Pulmonary Disease

Nicotine & its metabolites: apoptosis in developing neurons 2000 (Cycle 9) $412,200
Human BioMolecular Research Institute General Biomedical Science

Vascular endothelial growth factor receptor signaling 2000 (Cycle 9) $224,500
University of California, San Francisco Cardiovascular Disease

Regulation of cytokine production in pulmonary inflammation 2000 (Cycle 9) $93,268
University of California, San Diego Pulmonary Disease

Nitric oxide-dependent cell signaling in vascular cells 2000 (Cycle 9) $149,557
University of California, San Diego Cardiovascular Disease

New therapy for lung cancer using radioiodide 2000 (Cycle 9) $225,000
University of California, Los Angeles Cancer

1999 (Cycle 8)
Smoking & depression in Chinese vs. non-Chinese 1999 (Cycle 8) $225,000
University of California, San Francisco Tobacco-Use Prevention and Cessation

Regulation of lung inflammation by the LTC4 synthase pathway 1999 (Cycle 8) $225,000
University of California, San Diego Pulmonary Disease

Targeted blood clotting therapy for lung cancer 1999 (Cycle 8) $350,851
University of Southern California Cancer

Effects of exposure to secondhand smoke 1999 (Cycle 8) $194,404
Kaiser Foundation Research Institute Epidemiology

Activation of NF-kB by cigarette smoke 1999 (Cycle 8) $224,217
University of California, Davis Pulmonary Disease

Skeletal muscle structure and function in COPD 1999 (Cycle 8) $224,842
University of California, San Diego Pulmonary Disease

Carbon monoxide as a modulator of myocardial function 1999 (Cycle 8) $225,000
University of California, Davis Cardiovascular Disease

1998 (Cycle 7)
Neuroendocrine responses to nicotine: a physiologic probe 1998 (Cycle 7) $225,000
University of California, San Francisco Nicotine Dependence

Brain metabolic changes with cigarette craving 1998 (Cycle 7) $250,850
Brentwood Biomedical Research Institute Nicotine Dependence

How does cardiac fuel metabolism influence heart disease? 1998 (Cycle 7) $262,005
J. David Gladstone Institutes Cardiovascular Disease

An economic analysis of factors influencing teen smoking 1998 (Cycle 7) $221,497
University of California, San Diego Public Health, Public Policy, and Economics

Predictors of adolescent smoking initiation and cessation 1998 (Cycle 7) $224,374
University of California, San Diego Epidemiology

Susceptibility to smoking among adolescent never smokers 1998 (Cycle 7) $301,356
University of Southern California Epidemiology

Global determinants of tobacco use onset in diverse youth 1998 (Cycle 7) $280,749
Education Training and Research Associates, Inc. Epidemiology

1997 (Cycle 6)
Effects of tobacco on inflammatory cell responses 1997 (Cycle 6) $223,585
University of California, Davis Pulmonary Disease

Effect of sidestream smoke on lung injury and repair 1997 (Cycle 6) $214,070
University of California, Davis Pulmonary Disease

Motivational interviewing to prevent postpartum relapse 1997 (Cycle 6) $282,502
Kaiser Foundation Research Institute Tobacco-Use Prevention and Cessation

Noninvasive imaging of early atherosclerosis 1997 (Cycle 6) $101,923
University of California, San Diego Cardiovascular Disease

Interdependence - smoking behavior & mood in natural setting 1997 (Cycle 6) $222,843
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Role of viral-derived genes in lung cancer 1997 (Cycle 6) $375,800
Sidney Kimmel Cancer Center Cancer

Acculturation & cigarette smoking among Asian-Americans 1997 (Cycle 6) $244,715
University of Southern California Epidemiology

Alterations in gene expression after tobacco smoke exposure 1997 (Cycle 6) $216,612
University of California, Davis Pulmonary Disease

Brain wave assessment of tobacco cessation readiness 1997 (Cycle 6) $115,487
Scripps Research Institute Nicotine Dependence

The biological basis of nicotine addiction 1997 (Cycle 6) $224,949
University of California, Riverside Nicotine Dependence

Cigar use prevalence: social and media determinants 1997 (Cycle 6) $318,750
San Diego State University Research Foundation Public Health, Public Policy, and Economics

1995 (Cycle 4)
Nicotine & Neuroendocrine Cell Signalling in Fetal Lung 1995 (Cycle 4) $349,873
University of Southern California Pulmonary Disease

Vitronectin in Cardiovascular Disease 1995 (Cycle 4) $352,644
Scripps Research Institute Cardiovascular Disease

Functional Antagonists of Nicotine 1995 (Cycle 4) $236,936
Northern California Institute for Research & Education General Biomedical Science

Involvement of Lipids in Smoking-induced LDL Atherogenicity 1995 (Cycle 4) $175,844
Children's Hospital Oakland Research Institute Cardiovascular Disease

Role of Protein Phosphatases in Lung Cancer 1995 (Cycle 4) $363,234
University of Southern California Cancer

Gene Augmentation Therapy for Tobacco Induced Emphysema 1995 (Cycle 4) $224,786
University of California, Davis Pulmonary Disease

1994 (Cycle 3)
Environmental Tobacco Smoke & Epithelial Barrier Function 1994 (Cycle 3) $221,949
University of California, Davis Pulmonary Disease

Nicotinic Receptor Biology in CNS Neurons: An in vitro Model 1994 (Cycle 3) $225,000
University of California, San Diego Nicotine Dependence

Retinoblastoma Protein Dephosphorylation in Lung Cancer 1994 (Cycle 3) $250,223
Childrens Hospital, Los Angeles Cancer

Animal Models of Human Risk from Environmental Tobacco Smoke 1994 (Cycle 3) $135,482
University of California, Davis Epidemiology

Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis 1994 (Cycle 3) $175,409
Stanford University Cancer

Tobacco Use Among Hispanics in California 1994 (Cycle 3) $138,919
University of California, San Diego Public Health, Public Policy, and Economics

Political Activities of the Tobacco Industry in California 1994 (Cycle 3) $144,498
University of California, San Francisco Public Health, Public Policy, and Economics

Nicotine and Hemostatic Function of Brain Endothelium 1994 (Cycle 3) $342,880
University of Southern California Cardiovascular Disease

Endothelial Barrier Injury by Tobacco Smoke 1994 (Cycle 3) $225,000
University of California, Davis Cardiovascular Disease

Crowd Membership and Tobacco Use Among Young Adolescents 1994 (Cycle 3) $149,877
University of California, San Francisco Tobacco-Use Prevention and Cessation

p53 Mutations in Sporadic & Familial Childhood Tumors 1994 (Cycle 3) $213,407
University of California, Davis Cancer

Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis 1994 (Cycle 3) $43,318
University of California, San Francisco Cancer

Effects of Nicotine on Pulmonary Neuroendocrine Cell Growth 1994 (Cycle 3) $377,973
Doheny Eye Institute General Biomedical Science

Angiotensin II Regulation of the Cardiac Fibroblast 1994 (Cycle 3) $219,533
University of California, San Diego Cardiovascular Disease

Direct Analysis of Lung Cancer Development & Progression 1994 (Cycle 3) $336,973
University of Southern California Cancer

Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco 1994 (Cycle 3) $314,974
Stanford University Cardiovascular Disease

Addressing Substance Abusers Who Also Smoke 1994 (Cycle 3) $270,931
Northern California Institute for Research & Education Tobacco-Use Prevention and Cessation

1993 (Cycle 2)
The tobacco industry and scientific research 1993 (Cycle 2) $219,846
University of California, San Francisco Public Health, Public Policy, and Economics

Effects of passive smoking on sudden infant death syndrome 1993 (Cycle 2) $74,606
University of California, San Diego Epidemiology

Tumor Specific Antibodies 1993 (Cycle 2) $224,974
University of California, Davis Cancer

The Role of the Macrophage in Lung Cancer 1993 (Cycle 2) $215,007
University of California, Los Angeles Cancer

Stabilizing the Occlusion in the Dentate Hemimandibulectomy 1993 (Cycle 2) $104,037
University of California, San Francisco General Biomedical Science

Molecular Basis of Lung Cancer Metastasis 1993 (Cycle 2) $225,093
University of California, San Francisco Cancer

Relationship between tobacco use and abruption placentae 1993 (Cycle 2) $218,713
University of California, San Diego Epidemiology

A Metabolic Mechanism of Action of Antiischemic Agents 1993 (Cycle 2) $225,000
University of California, Los Angeles Cardiovascular Disease

Growth Control Pathways in Thyroid Follicular Epithelial Cells 1993 (Cycle 2) $224,759
University of California, San Diego General Biomedical Science

Factors Affecting Smoking Initiation in Young Latina Women 1993 (Cycle 2) $149,705
University of California, Los Angeles Public Health, Public Policy, and Economics

Effects of Cigarette Smoke on Nerve and Blood Vessel Growth 1993 (Cycle 2) $224,082
University of California, San Francisco General Biomedical Science

Diaphragm Structural and Metabolic Changes in Emphysema 1993 (Cycle 2) $224,988
University of California, San Diego Pulmonary Disease

Molecular Analysis of a DNA Repair Function 1993 (Cycle 2) $90,030
Salk Institute for Biological Studies General Biomedical Science

Function In Lung Matrix of a Laminin-Binding Lectin 1993 (Cycle 2) $244,977
University of California, San Francisco Pulmonary Disease

Impact of Nursing Care on Symptom Distress & Quality of Life 1993 (Cycle 2) $221,193
University of California, Los Angeles Public Health, Public Policy, and Economics

Effects of Cigarette Smoking in Low-Dose Zinc Fume Inhalation 1993 (Cycle 2) $225,000
University of California, San Francisco Epidemiology

1992 (Cycle 1)
Local Cytokine Immunotherapy for Lung Cancer 1992 (Cycle 1) $225,000
University of California, Los Angeles Cancer

Cigarette Smoke Expusure & Antioxidant Activity in Blood 1992 (Cycle 1) $260,359
Stanford University General Biomedical Science

Stem Cell Transplantation for Small & Non-small Cell Lung Cancers 1992 (Cycle 1) $174,666
University of California, Los Angeles Cancer

Effects of Cigarette Smoking on Leukocyte Adhesion Molecules 1992 (Cycle 1) $223,015
University of California, San Francisco General Biomedical Science

Tobacco-Related Carcinogens in Human Epithelial Cells 1992 (Cycle 1) $224,999
Lawrence Berkeley National Laboratory Cancer

Human Mast Cell Proteases: Function & Expression in Smoking-Induced Diseases 1992 (Cycle 1) $222,277
University of California, San Diego General Biomedical Science

Tumor Models & Radioimmunotherapy of Human Lung Cancers 1992 (Cycle 1) $12,382
University of Southern California Cancer

MS Studies of Tobacco -- Specific Adducts with Hemoglobin 1992 (Cycle 1) $225,000
University of California, San Francisco General Biomedical Science

A Smoking Prevention Model for Low Income Minority Youth 1992 (Cycle 1) $323,095
Charles R. Drew University of Medicine & Science Tobacco-Use Prevention and Cessation

Release of Pulmonary Peptides: Nicotine & Inflammation 1992 (Cycle 1) $223,588
University of California, San Diego Pulmonary Disease

Cytokines and Foam Cell Formation 1992 (Cycle 1) $321,593
Palo Alto Medical Foundation Research Institute General Biomedical Science

Preclinical Studies of Novel Agents for Lung Cancer 1992 (Cycle 1) $225,000
University of California, San Diego Cancer

Factors Required for K-RAS 4B Membrane Association & Activity 1992 (Cycle 1) $164,736
Scripps Research Institute General Biomedical Science

The Role of Tobacco Smoke in Multi-Step Carcinogenesis 1992 (Cycle 1) $341,730
Childrens Hospital, Los Angeles Cancer

Studies in Genotoxicity of Tobacco-Related Carcinogens 1992 (Cycle 1) $288,000
The Burnham Institute for Medical Research Cancer

Smoking & COPD: Effects on Cerebral Perfusion & Function 1992 (Cycle 1) $292,953
LA Biomedical Research Institute at Harbor-UCLA Medical Center Pulmonary Disease

Sidestream Smoke Effects on Immature Airway Receptors 1992 (Cycle 1) $211,744
University of California, Davis Pulmonary Disease

Tumor Suppressor Gene Mutations in Lung Cancer 1992 (Cycle 1) $333,054
University of Southern California Cancer

Cigarette Smoke Induced Changes in Gene Expression 1992 (Cycle 1) $222,046
University of California, Davis Cancer

Smoking Intervention for Women Seen in Primary Care Practice 1992 (Cycle 1) $218,178
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effects of Passive Smoking on Sudden Infant Death Syndrome 1992 (Cycle 1) $149,900
University of California, San Diego Epidemiology

Smoking-Related Risks for Small Cell Lung Cancer in Women 1992 (Cycle 1) $214,066
University of California, Irvine Epidemiology

Smoking Prevention for Hispanic Pregnant & Non-pregnant Adolescents 1992 (Cycle 1) $217,470
University of California, San Francisco Tobacco-Use Prevention and Cessation

Persistent Pulmonary Hypertension & Maternal Smoking 1992 (Cycle 1) $232,350
Children's Hospital Oakland Research Institute Pulmonary Disease

Characterization of a New Tumor Suppressor Gene 1992 (Cycle 1) $200,810
University of California, San Diego Cancer

Cigarette Smoke Expusure & Antioxidant Activity in Blood 1992 (Cycle 1) $74,439
Lawrence Berkeley National Laboratory General Biomedical Science

Tobacco Use In Pregnancy: Chronic Effects On Blood Flow 1992 (Cycle 1) $332,222
Cedars-Sinai Medical Center General Biomedical Science

Nicotine & The Heart: Potential Link to Sudden Death 1992 (Cycle 1) $150,000
University of California, San Francisco Cardiovascular Disease

NMYC Oncogene Expression in Small Cell Lung Cancer 1992 (Cycle 1) $225,000
University of California, Los Angeles Cancer

Nicotine & Cardiavascular Control During Exercise 1992 (Cycle 1) $220,302
University of California, Davis Cardiovascular Disease

Tumor Models & Radioimmunotherapy of Human Lung Cancers 1992 (Cycle 1) $202,062
City of Hope National Medical Center Cancer

Retinoic Acid Receptor Expression in Human Lung Cancer 1992 (Cycle 1) $204,590
University of California, Los Angeles Cancer

Tobacco Smoke, Benzene, & Mechanisms of Leukemogenesis 1992 (Cycle 1) $224,492
University of California, Riverside Cancer

Smoking-Induced Alteration of the Macrophage NADPH Oxidase 1992 (Cycle 1) $76,840
University of California, San Diego Pulmonary Disease

Family Intervention to Prevent Smoking: Preliminary Studies 1992 (Cycle 1) $123,704
Stanford University Tobacco-Use Prevention and Cessation

Diaphragm Cellular & Functional Adaptations to Emphysema 1992 (Cycle 1) $135,116
Cedars-Sinai Medical Center Pulmonary Disease